USPTO serial 79067273
YAMOKIN
Reviewed by CopyMark Law Group
Reg. 3787578Status 404
- Filing date
- Status date
- Registration date
- May 11, 2010
- Examiner
- KHAN, ASMAT A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with YAMOKIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
82152 Planegg/Martinsried, DE
82152 Planegg/Martinsried, DE
82152 Planegg/Martinsried, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Adrienne L. White
Adrienne L. White WRB-IP LLP1217 King StreetAlexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the prevention, treatment and diagnosis of diseases, in particular medicines, vaccines, serums and test kits comprised of small molecules, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-like particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration, all for the prevention, treatment and diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neurona1 tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basa1 cell carcinoma, squamous cell carcinoma, melanoma, kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, crohn's disease, lupus erythematosus and multiple sclerosis, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, bechterew's disease, fibromyalgia and lupus erythematosus, skin diseases, in particular warts, genital warts, bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 27, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 24, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 15, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 18, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 18, 2017 | INPC | INVALIDATION PROCESSED | — |
| Aug 16, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 16, 2016 | C71T | CANCELLED SECTION 71 | — |
| Feb 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 7, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 7, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 11, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 11, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 16, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 9, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 16, 2009 | ALIE | ASSIGNED TO LIE | — |
| Dec 1, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 26, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 1, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 1, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 31, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 1, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 30, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |